MLL1-inhibitorer og anticancermidler
The present invention provides a compound of Formula (I): or an enantiomer, an enantiomeric mixture, or a pharmaceutically acceptable salt thereof; wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds; and methods o...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | dan |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LU, Chunliang LIU, Kevin Kun Chin ZHU, Yihui LI, Ming SUN, Zhuming ZHAO, Jichen |
| description | The present invention provides a compound of Formula (I): or an enantiomer, an enantiomeric mixture, or a pharmaceutically acceptable salt thereof; wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds; and methods of using such compounds for treating a disease or condition mediated by mixed lineage leukemia 1 (MLL). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK4013756TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK4013756TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK4013756TT33</originalsourceid><addsrcrecordid>eNrjZFDx9fEx1M3My8hMyizJL0otUshPV0jMK8lMTsxLTi3KzUzJSS3iYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxLt4mBobG5qZmISHGxsSoAQD5wCb8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>MLL1-inhibitorer og anticancermidler</title><source>esp@cenet</source><creator>LU, Chunliang ; LIU, Kevin Kun Chin ; ZHU, Yihui ; LI, Ming ; SUN, Zhuming ; ZHAO, Jichen</creator><creatorcontrib>LU, Chunliang ; LIU, Kevin Kun Chin ; ZHU, Yihui ; LI, Ming ; SUN, Zhuming ; ZHAO, Jichen</creatorcontrib><description>The present invention provides a compound of Formula (I): or an enantiomer, an enantiomeric mixture, or a pharmaceutically acceptable salt thereof; wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds; and methods of using such compounds for treating a disease or condition mediated by mixed lineage leukemia 1 (MLL).</description><language>dan</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240527&DB=EPODOC&CC=DK&NR=4013756T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240527&DB=EPODOC&CC=DK&NR=4013756T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LU, Chunliang</creatorcontrib><creatorcontrib>LIU, Kevin Kun Chin</creatorcontrib><creatorcontrib>ZHU, Yihui</creatorcontrib><creatorcontrib>LI, Ming</creatorcontrib><creatorcontrib>SUN, Zhuming</creatorcontrib><creatorcontrib>ZHAO, Jichen</creatorcontrib><title>MLL1-inhibitorer og anticancermidler</title><description>The present invention provides a compound of Formula (I): or an enantiomer, an enantiomeric mixture, or a pharmaceutically acceptable salt thereof; wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds; and methods of using such compounds for treating a disease or condition mediated by mixed lineage leukemia 1 (MLL).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDx9fEx1M3My8hMyizJL0otUshPV0jMK8lMTsxLTi3KzUzJSS3iYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxLt4mBobG5qZmISHGxsSoAQD5wCb8</recordid><startdate>20240527</startdate><enddate>20240527</enddate><creator>LU, Chunliang</creator><creator>LIU, Kevin Kun Chin</creator><creator>ZHU, Yihui</creator><creator>LI, Ming</creator><creator>SUN, Zhuming</creator><creator>ZHAO, Jichen</creator><scope>EVB</scope></search><sort><creationdate>20240527</creationdate><title>MLL1-inhibitorer og anticancermidler</title><author>LU, Chunliang ; LIU, Kevin Kun Chin ; ZHU, Yihui ; LI, Ming ; SUN, Zhuming ; ZHAO, Jichen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK4013756TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LU, Chunliang</creatorcontrib><creatorcontrib>LIU, Kevin Kun Chin</creatorcontrib><creatorcontrib>ZHU, Yihui</creatorcontrib><creatorcontrib>LI, Ming</creatorcontrib><creatorcontrib>SUN, Zhuming</creatorcontrib><creatorcontrib>ZHAO, Jichen</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LU, Chunliang</au><au>LIU, Kevin Kun Chin</au><au>ZHU, Yihui</au><au>LI, Ming</au><au>SUN, Zhuming</au><au>ZHAO, Jichen</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>MLL1-inhibitorer og anticancermidler</title><date>2024-05-27</date><risdate>2024</risdate><abstract>The present invention provides a compound of Formula (I): or an enantiomer, an enantiomeric mixture, or a pharmaceutically acceptable salt thereof; wherein the variables are as defined herein. The present invention further provides pharmaceutical compositions comprising such compounds; and methods of using such compounds for treating a disease or condition mediated by mixed lineage leukemia 1 (MLL).</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | dan |
| recordid | cdi_epo_espacenet_DK4013756TT3 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | MLL1-inhibitorer og anticancermidler |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T19%3A34%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LU,%20Chunliang&rft.date=2024-05-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK4013756TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |